Technical Data

T9167-03
Clone Type
Polyclonal
Host
Goat
Source
Human
Isotype
IgG
Grade
Affinity Purified
Applications
E
Crossreactivity
Hu Mo Rt
Accession #
NP_009206.1
Shipping Temp
Blue Ice
Storage Temp
-20°C
Goat Anti-TUSC2 (Tumor Suppressor Candidate 2, C3orf11, FUS1, Fus-1 Protein, Fusion 1 Protein, LGCC, PAP, PDAP2, PDGFA-associated Protein 2, Tumor Suppressor Candidate 2)

This gene is a highly conserved lung cancer candidate gene. No other information about this gene is currently available.

Applications
Suitable for use in ELISA. Other applications not tested.
Recommended Dilution
ELISA:1:2000 Optimal dilutions to be determined by the researcher.
Storage and Stability
May be stored at 4°C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20°C. Aliquots are stable for at least 12 monthsat -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Peptide Blocking
Corresponding peptide is available for Peptide Blocking studies. See T9167-03-P. Antibody is typically 0.5mg/ml and peptide is supplied as a 100ul pellet. When peptide is reconstituted in 200ul water, the concentration would also be 0.5mg/ml. To start, the best ratio would be 1:1 (molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. It is best is to have two identical blots to be incubated with equal amount of antibody, but one with the antibody pre-adsorbed to the peptide for 20min. Then incubate and develop the two blots in parallel.
Immunogen
Synthetic peptide, C-TKNGQKRAKLRRVH, from the internal region of human TUSC2.
Form
Supplied as a liquid in Tris, pH 7.3, 0.5% BSA, 0.02% sodium azide.
Purity
Purified by immunoaffinity chromatography.
Specificity
Recognizes human TUSC2. Species sequence homology: mouse, rat.

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.

References
1. Deng WG, Kawashima H, Wu G, Jayachandran G, Xu K, Minna JD, Roth JA, Ji L. Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells. Cancer Res. 2007 Jan 15;67(2):709-17
USBio References
No references available
United States Biological | 4 Technology Way | Salem, MA 01970
Phone 800-520-3011 | Fax 978-594-8052 | Website www.usbio.net